研究员：杨松/张雪 机构：天风证券 事件： 国内市场发展稳健，海外市场增速亮眼 2025 年H1 中国大陆地区营业收入达8968.20 万美元，同比增长1.25%，海外收入达7167.20 万美元，同 比增长124.51%。在国内市场，公司前瞻性布局早期矫治与下沉市场，培育其成为业务稳定增长的驱动 力。在海外市场，公司凭借高质量的医学设计支持、稳定的交付，结合由关键意见领袖主导的持续性教 育培训以及为重要战略客户简单病例定制的矫治器等方式，扩大了海外市场覆盖范围。 海外案例数保持高速增长，主营业务稳步提升 2025 年H1，公司隐形矫治案例总数达22.58 万例，同比增长47.7%。国内隐形矫正案例总数约10.86 万 例，同比增长14.0%。海外隐形矫治案例总数约11.72 万例，同比增长103.5%。分业务看，公司的隐形 矫治解决方案收入8623.40 万美元，同比增长2.22%，主要原因系公司为应对中国内地市场的激烈竞争 而进行的策略性价格调整，促使达成的案例有所增加，但是该增长带来的效益部分已被产品的平均售价 下降所抵消；销售隐形矫治器收入7099.10 万美元，同比增长122.3%，主要原因系公司的 ...

港股公司报告 | 公司点评 时代天使（06699） 证券研究报告 全球业务增长强劲，产品创新提升诊疗效能 事件： 8 月 25 日，公司发布 2025 年中报。2025 年 H1 公司实现收入 1.61 亿美元， 同比增长 33.1%，归母净利润为 1464.30 万美元，同比增长 364.25%。经营 性现金流为 1753.50 万美元，同比增长 196.72%。 点评： 国内市场发展稳健，海外市场增速亮眼 2025 年 H1 中国大陆地区营业收入达 8968.20 万美元，同比增长 1.25%，海 外收入达 7167.20 万美元，同比增长 124.51%。在国内市场，公司前瞻性布 局早期矫治与下沉市场，培育其成为业务稳定增长的驱动力。在海外市场， 公司凭借高质量的医学设计支持、稳定的交付，结合由关键意见领袖主导 的持续性教育培训以及为重要战略客户简单病例定制的矫治器等方式，扩 大了海外市场覆盖范围。 海外案例数保持高速增长，主营业务稳步提升 2025 年 H1，公司隐形矫治案例总数达 22.58 万例，同比增长 47.7%。国内 隐形矫正案例总数约 10.86 万例，同比增长 14.0%。海外隐形矫治案 ...

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - The invisible orthodontics industry is experiencing rapid growth, with the number of new cases expected to reach approximately 5 million annually by 2025 globally, and over 500,000 in China [18][20] - The industry is characterized by a unique development pattern due to multidisciplinary integration and a complex supply chain, which necessitates collaboration and innovation [5][34] - Material science plays a crucial role in enhancing clinical outcomes, patient experience, and expanding application boundaries within the invisible orthodontics sector [13][71] Summary by Sections Section 1: New Foundations - Industry Collaborative Evolution - The global orthodontic market has maintained healthy growth over the past 30 years, with a significant increase in invisible orthodontic cases, transitioning from niche to mainstream [18] - The demand for invisible orthodontics is driven by changing perceptions of oral health, aesthetic demands, and advancements in technology [20][21] Section 2: Core of Quality - The Triple Guardian Power of Material Science - Reliable medical-grade materials are essential for ensuring the safety and effectiveness of invisible orthodontic devices [39][43] - The efficiency of orthodontic treatment is significantly influenced by the properties of the materials used, which must align with clinical needs [47][49] - Patient experience is enhanced through materials that offer high optical transparency, durability, and comfort, which in turn increases compliance with treatment [52][57] Section 3: Future Path - Material Science Empowering Industry Development - The industry is moving towards a more collaborative ecosystem, where material suppliers, manufacturers, and clinical practitioners work together to enhance product performance and patient outcomes [34][72] - Innovations in material science are expected to broaden the application scope of invisible orthodontics, integrating additional functionalities such as antibacterial properties and teeth whitening [71] - The report emphasizes the importance of building a sustainable and innovative ecosystem through open collaboration among industry partners [75][76]

Core Viewpoint - The article emphasizes the importance of oral health as a crucial component of overall health, highlighting the necessity of regular dental check-ups and treatments such as teeth cleaning and orthodontics to maintain dental hygiene and prevent further complications [1][2][3]. Group 1: Importance of Regular Dental Care - Regular dental cleaning is essential to remove plaque and tartar, which can lead to various dental diseases if not addressed [2][3]. - Recommendations for cleaning frequency include every six months to a year for healthy individuals, and every three to six months for those with periodontal disease [2]. - The use of electric toothbrushes can enhance brushing efficiency, particularly for individuals with limited hand mobility [2]. Group 2: Orthodontic Treatment - Various dental issues warrant orthodontic treatment, including misaligned teeth, large gaps, deep bites, and other malocclusions [3][4]. - Preparation for orthodontic treatment involves a thorough examination by a professional orthodontist, including X-rays and dental scans [4]. - Two main types of orthodontic devices are discussed: removable and fixed braces, each with its own advantages and disadvantages [4][5]. Group 3: Dental Implants - Missing teeth can lead to significant functional and aesthetic issues, making dental implants a viable solution [7][8]. - Dental implants involve placing a titanium root in the jawbone, which integrates with the bone over time, providing a stable foundation for artificial teeth [7][8]. - Candidates for dental implants should be in good health and have adequate bone structure, while certain health conditions may require further evaluation before proceeding [8].

Core Viewpoint - Angelalign (06699) reported strong mid-year performance with significant revenue and profit growth, driven by international market expansion and increased case numbers [1] Financial Performance - The company's revenue for the first half of the year was $161.4 million, a year-on-year increase of 33.1% [1] - Adjusted net profit reached $19.5 million, up 84.8% compared to the previous year [1] - Profit attributable to shareholders was $14.64 million, reflecting a substantial year-on-year growth of 362.65% [1] Market Expansion - The total number of invisible orthodontic cases increased by 47.7% year-on-year, reaching approximately 225,800 cases [1] - International market cases surged by 103.5% year-on-year, totaling about 117,200 cases, surpassing the domestic market's 108,600 cases [1] Analyst Insights - Goldman Sachs noted that Angelalign's revenue of $161 million exceeded their expectations, primarily due to rapid overseas business expansion [1] - The gross margin remained stable at 62.4%, consistent with the same period last year, while the overseas gross margin improved from 58.3% to 61.2% [1] Future Guidance - Management has raised the annual case volume guidance to between 490,000 and 500,000, indicating a year-on-year growth of 36% to 39% [1]

Core Insights - Angelalign reported strong 1H25 results with revenue increasing 33% YoY to US$161 million, driven by rapid overseas business expansion [1] - Total clear aligner case volume reached 225,800, up 48% YoY, exceeding the historical average of ~41% [1] - Attributable net profit margin improved significantly to 9.1%, supported by effective cost control measures [1] Domestic Business - Domestic clear aligner case shipments reached 108,600, a 14% YoY increase, driven by strategic price adjustments [2] - Despite solid volume growth, domestic revenue remained flat at US$90 million compared to 1H24 due to ASP reduction [2] - Pricing pressure is expected to persist, influenced by high patient price sensitivity and recent aligner VBP renewal in Shaanxi [2] Overseas Business - Overseas clear aligner case shipments reached 117,200, a 103% YoY increase, with revenue increasing 123% YoY to US$72 million [3] - Operating losses narrowed to US$5 million, primarily due to delayed staff recruitment and operation of overseas manufacturing facilities [3] - Expected widening of operating losses in 2H25E due to increased marketing spending, lower GPM, and higher tariffs [3] Investment Outlook - The company maintains a BUY rating, raising forecasts for 2025E case shipments and revenue based on stronger-than-expected growth in 1H25 [4] - A target price of HK$86.47 is derived from SOTP valuation, assigning 15x 2025E P/E to the domestic business and 8x 2025E P/S to the overseas business [4]

Investment Rating - The report maintains an "Outperform" rating for the company, with a target price of HKD 103.5 per share, indicating a potential upside from the current price of HKD 69.10 [2][5][14]. Core Insights - The company's revenue and profit for the first half of 2025 exceeded market expectations, driven by stabilization in domestic operations and rapid growth in overseas markets [3][10]. - In 1H25, the company achieved revenue of USD 160 million, representing a 33.1% increase year-over-year, with domestic revenue at USD 89.68 million (+0.6%) and overseas revenue at USD 71.67 million (+123.1%) [3][10][11]. - The share of overseas revenue reached 44.4%, up 17.9 percentage points, highlighting its importance as a key revenue source [3][10]. - The number of clear-aligner cases completed in 1H25 was 226,000, a 47.7% increase, with domestic cases growing by 14.0% and overseas cases surging by 103.5% [11][12]. Financial Performance - The gross margin for 1H25 was stable at 62.4%, while adjusted net profit increased by 84.8% to USD 19.47 million, resulting in a net margin of 12.1% [4][13]. - The company plans to implement aggressive market strategies in the second half of 2025 to maintain market share and continue its overseas expansion [5][14]. - Revenue forecasts for 2025 and 2026 have been raised to USD 340 million and USD 420 million, respectively, reflecting stronger-than-expected overseas growth [5][14]. Valuation Metrics - The report projects adjusted net profits of USD 26.75 million for 2025 and USD 32.80 million for 2026, with corresponding P/E ratios of 85x and 70x [5][14]. - The company is positioned as a leader in the clear-aligner market in China, with its overseas growth trajectory being increasingly validated [5][14].

Investment Rating - The report indicates a positive outlook for the invisible orthodontics industry, projecting a compound annual growth rate (CAGR) of 13.9% from 2024 to 2030, with market size expected to grow from 145 billion to 316 billion yuan [16][17]. Core Insights - The invisible orthodontics market in China is characterized by a large patient population, with over 1 billion individuals suffering from malocclusion, and a significantly higher prevalence of complex cases (Class II/III) compared to Western countries [4][20]. - The industry is currently dominated by two major players, Angelalign and Invisalign, which have established a "dual oligopoly" market structure, leading to intense competition and innovation [6][35]. - The report highlights the increasing demand for invisible orthodontics driven by rising consumer awareness of aesthetics and comfort, as well as advancements in technology such as AI design and 3D printing [17][38]. Summary by Sections Industry Overview - Malocclusion is defined as a dental condition resulting from abnormal jaw relationships, affecting oral health and function, necessitating orthodontic treatment [3][7]. - The prevalence of malocclusion in China is notably high, with complex cases reaching 45-50%, significantly above the 20-40% range seen in Europe and America [4][20]. Market Size - The market size for invisible orthodontics in China is projected to increase from 100 billion yuan in 2019 to 145 billion yuan in 2024, and further to 316 billion yuan by 2030 [16][17]. - The demand for invisible orthodontics is expected to rise due to improved consumer aesthetics awareness and the effectiveness of invisible aligners compared to traditional methods [17]. Supply Chain Analysis - The supply chain consists of upstream suppliers of orthodontic materials, midstream service providers, and downstream dental institutions, with a notable trend towards digital integration and efficiency [5][26]. - The core material for invisible aligners has transitioned from imported monopolies to domestic production, stabilizing the market with key players like Angelalign and Invisalign [5][29]. Competitive Landscape - The competitive landscape is marked by a "dual oligopoly" led by Angelalign and Invisalign, with both companies leveraging continuous technological advancements and clinical data to maintain their market positions [6][35]. - The report notes that the introduction of centralized procurement in 2022 has led to significant price reductions, enhancing affordability and market penetration, especially in lower-tier cities [22][23]. Technological Advancements - Innovations in materials, such as the development of PETG and TPU for aligners, have improved treatment outcomes and patient comfort [29][38]. - The integration of AI and 3D printing technologies is expected to further enhance the precision and efficiency of orthodontic treatments, creating opportunities for new entrants in the market [38].

Core Viewpoint - Goldman Sachs has raised the target price for Angelalign Technology (06699) from HKD 78.8 to HKD 81.3, maintaining a "Buy" rating based on the Sum of the Parts (SOTP) valuation method [1] Financial Performance - Angelalign's revenue for the first half reached USD 161 million, representing a year-on-year increase of 33%, exceeding Goldman Sachs' expectations, primarily driven by rapid expansion in overseas markets [1] - The gross margin remained stable at 62.4%, unchanged from the same period last year, despite strategic price adjustments in domestic operations [1] - The overseas gross margin improved from 58.3% in the same period last year to 61.2% [1] Guidance and Projections - Management has raised the annual case volume guidance to between 490,000 and 500,000, indicating a year-on-year growth of 36% to 39% [1]

Group 1 - The core viewpoint of the news is that Times Angel (06699) experienced a significant stock price increase following the announcement of its mid-year results for 2025, with a rise of 10.28% to HKD 75.1 and a trading volume of HKD 573 million [1] - For the first half of 2025, the company reported revenue of USD 161.4 million, a year-on-year increase of 33.1%, and a gross profit of approximately USD 100 million, up 32.9% year-on-year [1] - The adjusted net profit reached USD 19.5 million, reflecting an impressive year-on-year growth of 84.8%, while the profit attributable to shareholders surged to USD 14.64 million, marking a substantial increase of 362.65% [1] - The total number of invisible orthodontic cases grew significantly by 47.7% year-on-year, reaching approximately 225,800 cases, with international market cases increasing by 103.5% to about 117,200 cases, surpassing the domestic market's 108,600 cases [1] Group 2 - Times Angel announced an investment agreement where its wholly-owned subsidiary, Wuxi Times Angel, will invest RMB 10 million to acquire a 5% stake in Shanghai Markofis, a leading supplier of materials, components, and equipment in the invisible orthodontic industry [2] - Following the investment, the group will effectively hold approximately 9.7% equity interest in Shanghai Markofis [2] - The board believes that securing reliable raw material suppliers and establishing long-term partnerships is crucial due to the increasing demand for materials driven by the growth of the invisible orthodontic business [2]